Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial. - Zielinski,C..; Beslija,S..; Mrsic-Krmpotic,Z..; et,al.. (J Clin Oncol, 2005)